Sanctuary Advisors LLC acquired a new stake in LENSAR, Inc. (NASDAQ:LNSR – Free Report) during the second quarter, according to its most recent filing with the SEC. The firm acquired 20,620 shares of the company’s stock, valued at approximately $93,000. Sanctuary Advisors LLC owned about 0.18% of LENSAR as of its most recent filing with the SEC.
Separately, DCF Advisers LLC lifted its stake in shares of LENSAR by 1.4% during the second quarter. DCF Advisers LLC now owns 241,484 shares of the company’s stock valued at $1,087,000 after acquiring an additional 3,250 shares during the period. Institutional investors own 40.15% of the company’s stock.
LENSAR Stock Up 0.9 %
Shares of LNSR stock opened at $5.52 on Tuesday. The firm has a market cap of $62.91 million, a price-to-earnings ratio of -3.49 and a beta of 0.64. LENSAR, Inc. has a 12 month low of $1.80 and a 12 month high of $6.25. The stock has a 50-day moving average price of $4.63 and a 200 day moving average price of $4.35.
About LENSAR
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
Further Reading
- Five stocks we like better than LENSAR
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- Breakout Stocks: What They Are and How to Identify Them
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.